Takeda files NDA for subcutaneous formulation of Vedolizumab

Takeda Pharmaceutical Company Limited has submitted a New Drug Application (NDA) to the Ministry of Health, Labour and W...

August 21, 2019 | Wednesday | News
Japanese scientists develop 3D printed prosthetic hand

The Biological Systems Engineering Lab at Hiroshima University, Japan has developed a new 3D printed prosthetic hand com...

August 16, 2019 | Friday | News
Shimadzu receives FDA clearance for FLUOROspeed X1

Shimadzu Medical Systems, a subsidiary of Shimadzu Corporation Japan, is proud to announce that they have received FDA 5...

August 14, 2019 | Wednesday | News
OssDsign AB files regulatory approval for OssDsign Cranial in Japan

OssDsign AB (publ), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a ...

August 12, 2019 | Monday | News
Eisai refreshes medical skin care product Sahne

Eisai Co., Ltd. has announced that it refresh its SAHNE® CREAM (quasi-drug) which has been widely used as medic...

August 9, 2019 | Friday | News
Astellas Initiates Phase 3 Clinical Trials for Fezolinetant

Japan based Astellas Pharma Inc. has announced dosing of the first patient in the SKYLIGHT 1™ Phase 3 pivotal tria...

August 8, 2019 | Thursday | News
Pola Orbis to create unique value in dermatology

POLA Chemical Industries, Inc. Frontier Research Center (FRC) of POLA ORBIS Holdings Inc. and one of the world's top res...

August 7, 2019 | Wednesday | News
FDA approves Daiichi Sankyo's TURALIO

Daiichi Sankyo Company has announced that the U.S. Food and Drug Administration (FDA) approved TURALIO™(pexidartin...

August 5, 2019 | Monday | News
Sosei Heptares, Takeda enter into multi-target partnership

Sosei Group Corporation has announced that it has entered into a strategic multi-target partnership with Takeda Pharmace...

August 6, 2019 | Tuesday | News
Rakuten Medical to further develop its photo-immunotherapy

Rakuten Medical, Inc., a clinical-stage, global biotechnology company developing precision-targeted cancer therapies bas...

August 5, 2019 | Monday | News
Sysmex gets Japanese manufacturing and marketing approval

Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM™ RAS CRC Kit, ...

August 2, 2019 | Friday | News
Morimoto Pharma unveils new Exposure Prevention Prefilled Syringe Kits

Japanese firm Morimoto Pharma has revealed their new prefilled syringe product, the Morimoto S.A.F.E. Syringe ...

August 5, 2019 | Monday | News
Fujifilm completes acquisition of Biogen's Manufacturing Site in Denmark

FUJIFILM Corporation has announced that it has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-...

August 2, 2019 | Friday | News
Marken acquires PCX International to strengthen supply chain footprint

Marken, a US headquartered patient-centric supply chain organization, has announced  the acquisition of PCX Interna...

August 2, 2019 | Friday | News
Kyowa Kirin buys back Tivozanib rights from AVEO oncology

Japan based pharma company Kyowa Kirin Co. and US headquartered AVEO Oncology announce that they have amended their lice...

August 2, 2019 | Friday | News
Sun Pharma announces regulatory filing of Tildrakizumab in Japan

Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has filed an application for ...

August 1, 2019 | Thursday | News
Takeda, Pfizer terminate co-promotion of RA Drug Enbrel

Pfizer Japan Inc. and Takeda Pharmaceutical Company Limited have announced the termination of co-promotion for the rheum...

July 31, 2019 | Wednesday | News
NEC acquires OncoImmunity AS to empower personalized cancer immunotherapy

OncoImmunity AS has announced that it has been acquired by NEC Corporation, the renowned Japanese IT and network co...

July 30, 2019 | Tuesday | News
Scientists in Japan develop prosthetics for retinal stimulation

In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University in Japan report...

July 29, 2019 | Monday | News
Astellas submits biologics license application for Urothelial Cancer drug

Japan based Astellas Pharma Inc. and US headquartered Seattle Genetics, Inc. have announced submission of a Bi...

July 26, 2019 | Friday | News
Akebia submits new application for anemia drug in Japan

Akebia Therapeutics, Inc.  has announced that Mitsubishi Tanabe Pharma Corporation (MTPC), its development and comm...

July 24, 2019 | Wednesday | News
Eisai, Merck receive breakthrough therapy designation from FDA

Japanese pharmaceutical firm Eisai, and Merck & Co., Inc., Kenilworth, N.J., U.S.A., known as MSD outside th...

July 23, 2019 | Tuesday | News
Bayer, BMS, Ono Pharma enter into clinical collaboration for colorectal cancer

German pharma company Bayer, US based Bristol-Myers Squibb (BMS) Company and Japan headquartered Ono Pharmaceutical Co.,...

July 22, 2019 | Monday | News
Takeda, Kyoto University research collaboration develops further

The Center for iPS Cell Research and Application (CiRA) at Kyoto University and Takeda Pharmaceutical Company Limited (&...

July 18, 2019 | Thursday | News
Sosei Heptares teams up with Genentech for multi-target R&D

Japan headquartered Sosei Group Corporation has entered into a multi-target research collaboration and license agreement...

July 17, 2019 | Wednesday | News